• AstraZeneca PLC (AZN) CEO in Line for $65 Million Goodbye More...
• China Biologic Products Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO More...
• Array BioPharma, Inc. (ARRY) Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors More...
• New Leaf Venture Partners' Liam Ratcliffe, M.D., Ph.D., Elected to Array BioPharma, Inc. (ARRY)'s Board of Directors More...
• Eyitayo S. Fakunle, Ph.D., Head of CalAsia Pharmaceuticals Translational Research More...
• Balchem Corporation (BCPC) to Build Plant in Alleghany County, Creating 55 New Jobs More...
• Pfizer Inc. (PFE) May Unload Animal Health Unit in IPO More...
• Warner Chilcott, PLC (WCRX) Weighs Sale, Other Options: Report More...
• GlaxoSmithKline (GSK) Bid Undervalues Human Genome Sciences, Inc. (HGSI) More...
• MannKind Corporation (MNKD), Tolero Ink $130 Million Development Pact More...
• Pharmaceutical Company Merck Serono Signs an Agreement to UseKadimastem's Platform for Drug Screening More...
• Altor BioScience Corporation and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor's Novel IL-15 Superagonist for Metastatic Melanoma More...
• Cerus Corporation (CERS), the University Hospitals of Geneva, and theTransfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa More...
• TKL Research, Inc. Selects Medidata Solutions, Inc.' Clinical Trial Management System to Drive Future Growth More...
• Dynavax Technologies Corporation (DVAX) Reports First Quarter 2012 Financial Results More...
• Flamel Technologies (FLML) Announces Projected Release Date of First Quarter 2012 Results and Conference Call More...
• Polydex Pharmaceuticals (POLXF) Reports Profitability In 2012 Fiscal Year End Financial Results More...
• Repligen Corporation (RGEN) Announces Conference Call to Report First Quarter of 2012 Financial Results More...
• Somaxon Pharmaceuticals, Inc. (SOMX) to Report First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10 More...
• Pfizer Inc. (PFE) Says Brigham Young University Tainted Utah Jury Pool for Trial in Multibillion Dollar Celebrex Case More...
• Merck & Co., Inc. (MRK) Wins Two Patent Lawsuits Against Mylan Pharmaceuticals, Inc. (MYL) More...
• Teva Pharmaceutical Industries Limited (TEVA) Settles Nuvigil Litigation with Mylan Inc. (MYL) More...
• China Biologic Products Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO More...
• Array BioPharma, Inc. (ARRY) Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors More...
• New Leaf Venture Partners' Liam Ratcliffe, M.D., Ph.D., Elected to Array BioPharma, Inc. (ARRY)'s Board of Directors More...
• Eyitayo S. Fakunle, Ph.D., Head of CalAsia Pharmaceuticals Translational Research More...
• Balchem Corporation (BCPC) to Build Plant in Alleghany County, Creating 55 New Jobs More...
• Pfizer Inc. (PFE) May Unload Animal Health Unit in IPO More...
• Warner Chilcott, PLC (WCRX) Weighs Sale, Other Options: Report More...
• GlaxoSmithKline (GSK) Bid Undervalues Human Genome Sciences, Inc. (HGSI) More...
• MannKind Corporation (MNKD), Tolero Ink $130 Million Development Pact More...
• Pharmaceutical Company Merck Serono Signs an Agreement to UseKadimastem's Platform for Drug Screening More...
• Altor BioScience Corporation and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor's Novel IL-15 Superagonist for Metastatic Melanoma More...
• Cerus Corporation (CERS), the University Hospitals of Geneva, and theTransfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa More...
• TKL Research, Inc. Selects Medidata Solutions, Inc.' Clinical Trial Management System to Drive Future Growth More...
• Dynavax Technologies Corporation (DVAX) Reports First Quarter 2012 Financial Results More...
• Flamel Technologies (FLML) Announces Projected Release Date of First Quarter 2012 Results and Conference Call More...
• Polydex Pharmaceuticals (POLXF) Reports Profitability In 2012 Fiscal Year End Financial Results More...
• Repligen Corporation (RGEN) Announces Conference Call to Report First Quarter of 2012 Financial Results More...
• Somaxon Pharmaceuticals, Inc. (SOMX) to Report First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10 More...
• Pfizer Inc. (PFE) Says Brigham Young University Tainted Utah Jury Pool for Trial in Multibillion Dollar Celebrex Case More...
• Merck & Co., Inc. (MRK) Wins Two Patent Lawsuits Against Mylan Pharmaceuticals, Inc. (MYL) More...
• Teva Pharmaceutical Industries Limited (TEVA) Settles Nuvigil Litigation with Mylan Inc. (MYL) More...
0 comments